Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1991 2
1992 2
1993 1
1994 4
1995 2
1998 1
1999 2
2000 4
2001 2
2002 4
2003 11
2004 8
2005 6
2006 4
2007 3
2008 4
2009 5
2010 8
2011 11
2012 10
2013 6
2014 8
2015 11
2016 17
2017 17
2018 12
2019 13
2020 8
2021 11
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
Bowman SJ, Fox R, Dörner T, Mariette X, Papas A, Grader-Beck T, Fisher BA, Barcelos F, De Vita S, Schulze-Koops H, Moots RJ, Junge G, Woznicki JN, Sopala MA, Luo WL, Hueber W. Bowman SJ, et al. Among authors: moots rj. Lancet. 2022 Jan 8;399(10320):161-171. doi: 10.1016/S0140-6736(21)02251-0. Epub 2021 Nov 30. Lancet. 2022. PMID: 34861168 Clinical Trial.
Behcet's disease.
Nair JR, Moots RJ. Nair JR, et al. Among authors: moots rj. Clin Med (Lond). 2017 Feb;17(1):71-77. doi: 10.7861/clinmedicine.17-1-71. Clin Med (Lond). 2017. PMID: 28148585 Free PMC article.
Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.
Bowman SJ, Everett CC, O'Dwyer JL, Emery P, Pitzalis C, Ng WF, Pease CT, Price EJ, Sutcliffe N, Gendi NST, Hall FC, Ruddock SP, Fernandez C, Reynolds C, Hulme CT, Davies KA, Edwards CJ, Lanyon PC, Moots RJ, Roussou E, Giles IP, Sharples LD, Bombardieri M. Bowman SJ, et al. Among authors: moots rj. Arthritis Rheumatol. 2017 Jul;69(7):1440-1450. doi: 10.1002/art.40093. Epub 2017 Jun 5. Arthritis Rheumatol. 2017. PMID: 28296257 Free article. Clinical Trial.
The Behçet's centres of excellence.
Moots RJ, Fortune F, Situnayake D. Moots RJ, et al. Rheumatology (Oxford). 2018 Apr 1;57(4):594-595. doi: 10.1093/rheumatology/kex037. Rheumatology (Oxford). 2018. PMID: 28340170 No abstract available.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R, Mysler E, Hall S, Kivitz AJ, Moots RJ, Luo Z, DeMasi R, Soma K, Zhang R, Takiya L, Tatulych S, Mojcik C, Krishnaswami S, Menon S, Smolen JS; ORAL Strategy investigators. Fleischmann R, et al. Among authors: moots rj. Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16. Lancet. 2017. PMID: 28629665 Clinical Trial.
A Darwinian View of Behçet's Disease.
Smith R, Moots RJ, Murad M, Wallace GR. Smith R, et al. Among authors: moots rj. Rheumatol Immunol Res. 2021 Sep 28;2(2):91-99. doi: 10.2478/rir-2021-0013. eCollection 2021 Jun. Rheumatol Immunol Res. 2021. PMID: 36465976 Free PMC article. Review.
Behcet's syndrome.
Hart M, Moots RJ. Hart M, et al. Among authors: moots rj. BMJ. 2009 Oct 5;339:b3876. doi: 10.1136/bmj.b3876. BMJ. 2009. PMID: 19805471 No abstract available.
Etanercept for the treatment of rheumatoid arthritis.
Zhao S, Mysler E, Moots RJ. Zhao S, et al. Among authors: moots rj. Immunotherapy. 2018 Mar 1;10(6):433-445. doi: 10.2217/imt-2017-0155. Epub 2018 Feb 27. Immunotherapy. 2018. PMID: 29482402 Review.
Working at arthritis.
Short P, Jones AC, Walker D, Kavanaugh A, Moots RJ. Short P, et al. Among authors: moots rj. Rheumatology (Oxford). 2012 Feb;51(2):201-3. doi: 10.1093/rheumatology/ker415. Epub 2011 Dec 16. Rheumatology (Oxford). 2012. PMID: 22179726 No abstract available.
182 results